Companies: 10,795·Total market cap: $144.5T
Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited

NURPFOTCHealthcare● Active
$9.25
+$0.38(+4.23%)
Market Cap$1.2B
P/E Ratio—
52W High$14.7965
52W Low$7.7
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Neuren Pharmaceuticals Limited（NURPF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NURPF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$1.33nurpf eps ttm · nurpf earnings per shareEarnings history
PE Ratio (TTM)6.9×nurpf pe ratio ttm · nurpf price to earningsPE Ratio deep dive
Revenue (TTM)$281.5Mnurpf revenue ttm · nurpf annual revenueFull revenue history
Dividend Yield不分红does nurpf pay dividends · nurpf dividend yieldDividend history
Shares Outstanding128.2Mnurpf shares outstanding · nurpf floatShares outstanding history
Next EarningsAug 25, 2026Est.nurpf earnings date · nurpf next earningsEarnings history

探索 Neuren Pharmaceuticals Limited 数据

nurpf stock data · financials
市值$1.2Bnurpf market cap · nurpf valuation
分析师预测—
股息不分红does neuren pharmaceuticals limited pay dividends · nurpf dividend yield
营收$64.6M-70.20%neuren pharmaceuticals limited annual revenue · nurpf revenue
盈利EPS $0.24-77.98%nurpf earnings · nurpf eps
市盈率6.9×nurpf pe ratio · nurpf price to earnings

财务快照

完整财报
FY 2025Revenue$64.6M▼ 70.20% YoY
202320242025
neuren pharmaceuticals limited revenue · nurpf revenue 2025
FY 2025Net Income$30.4M▼ 78.58% YoY
202320242025
neuren pharmaceuticals limited net income · nurpf profit 2025
FY 2025EPS$0.24▼ 77.98% YoY
202320242025
nurpf eps · neuren pharmaceuticals limited earnings per share 2025
TTM:Revenue: $281.5MNet Income: $172.5MEPS: $1.33View income statement →

股票表现

完整历史
1D+4.23%
1W+4.17%
1M+4.88%
3M+8.57%
YTD-28.35%
1Y+4.40%
5Y+839.09%

关于 Neuren Pharmaceuticals Limited

CEOJonathan Charles Pilcher
IPO DateNov 4, 2009
Employees8
CountryAU
Websiteneurenpharma.com

Neuren Pharmaceuticals Limited is a biopharmaceutical company specializing in the development of treatments for neurological conditions. Their leading therapeutic compound, trofinetide, is currently u…

BiotechnologyHealthcareOTCAU

what is neuren pharmaceuticals limited · nurpf stock overview · neuren pharmaceuticals limited company profile · who is neuren pharmaceuticals limited ceo · nurpf OTC · neuren pharmaceuticals limited headquarters · neuren pharmaceuticals limited business segments

关于股票概览与关键数据

Neuren Pharmaceuticals Limited（NURPF）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 4, 2009 在 OTC 上市。截至最近交易日，NURPF 股价为 $9.25，市值约为 $1.2B。过去12个月累计回报 +4.40%，年初至今回报 -28.35%。

2025 财年 Neuren Pharmaceuticals Limited 营收 $64.6M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Neuren Pharmaceuticals Limited（NURPF）股价为 $9.25，在 OTC 上市，52周区间为 $7.70 – $14.80。

NURPF 最新股价NURPF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议